Incidence and prevalence of non-melanoma skin cancer in Australia: A systematic review

被引:150
作者
Perera, Eshini [1 ,4 ]
Gnaneswaran, Neiraja [1 ]
Staines, Carolyn [3 ]
Win, Aung Ko [2 ]
Sinclair, Rod [1 ,4 ]
机构
[1] Univ Melbourne, Dept Med, Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic 3010, Australia
[3] Canc Council Victoria, Melbourne, Vic, Australia
[4] Sinclair Dermatol, Melbourne, Vic, Australia
关键词
basal cell carcinoma; epidemiology; incidence; keratinocyte cancer; non-melanoma skin cancer; non melanoma; nonmelanoma; prevalence; squamous cell carcinoma; MEDICARE CLAIMS DATA; WESTERN-AUSTRALIA; NATIONAL-SURVEY; POPULATION; QUEENSLAND; TRENDS; RATES; CARCINOMA; GERALDTON;
D O I
10.1111/ajd.12282
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Non-melanoma skin cancer (NMSC), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), is the most common cancer occurring in people with fair skin. Australia has been reported to have the highest incidence of NMSC in the world. Using a systematic search of the literature in EMBASE and Medline, we identified 21 studies that investigated the incidence or prevalence of NMSC in Australia. Studies published between 1948 and 2011 were identified and included in the analysis. There were six studies that were conducted on national level, two at state level and 13 at the regional level. Overall, the incidence of NMSC had steadily increased over calendar-years in Australia. The incidence of NMSC per 100 000 person-years was estimated to be 555 in 1985; 977 in 1990; 1109 in 1995; 1170 in 2002 and 2448 in 2011. The incidence was higher for men than women and higher for BCC than SCC. Incidence varied across the states of Australia, with the highest in Queensland. The prevalence of NMSC was estimated to be 2% in Australia in 2002. The incidence and prevalence of NMSC still need to be accurately established at both national and state levels to determine the costs and burden of the disease on the public health system in Australia.
引用
收藏
页码:258 / 267
页数:10
相关论文
共 50 条
  • [31] The Association of Vitamin D with Non-Melanoma Skin Cancer Risk: An Umbrella Review of Systematic Reviews and Meta-Analyses
    Seretis, Konstantinos
    Bounas, Nikolaos
    Sioka, Chrissa
    MEDICINA-LITHUANIA, 2023, 59 (12):
  • [32] Hydrochlorothiazide treatment and risk of non-melanoma skin cancer: Review of the literature
    Miguel Garrido, Pedro
    Borges-Costa, Joao
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2020, 39 (03) : 163 - 170
  • [33] The State of the Art of Radiotherapy for Non-melanoma Skin Cancer: A Review of the Literature
    Benkhaled, Sofian
    Van Gestel, Dirk
    Gomes da Silveira Cauduro, Carolina
    Palumbo, Samuel
    del Marmol, Veronique
    Desmet, Antoine
    FRONTIERS IN MEDICINE, 2022, 9
  • [34] Non-Melanoma Skin Cancer Detection in the Age of Advanced Technology: A Review
    Stafford, Haleigh
    Buell, Jane
    Chiang, Elizabeth
    Ramesh, Uma
    Migden, Michael
    Nagarajan, Priyadharsini
    Amit, Moran
    Yaniv, Dan
    CANCERS, 2023, 15 (12)
  • [35] Evaluating Difluoromethylornithine Safety and Efficacy for Non-Melanoma Skin Cancer Chemoprevention: A Systematic Review
    Koulmi, Kaouthar
    Cattelan, Leila
    Litvinov, Ivan V.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024, : 143 - 149
  • [36] Efficacy of hypofractionated radiotherapy in patients with non-melanoma skin cancer: Results of a systematic review
    Gunaratne, Dakshika A.
    Veness, Michael J.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2018, 62 (03) : 401 - 411
  • [37] Attitudes among dermatologists regarding non-melanoma skin cancer treatment options
    Fania, Luca
    Samela, Tonia
    Moretta, Gaia
    Ricci, Francesco
    Dellambra, Elena
    Mancini, Mara
    Sampogna, Francesca
    Panebianco, Annarita
    Abeni, Damiano
    DISCOVER ONCOLOGY, 2021, 12 (01)
  • [38] HIV Infection Status, Immunodeficiency, and the Incidence of Non-Melanoma Skin Cancer
    Silverberg, Michael J.
    Leyden, Wendy
    Warton, E. Margaret
    Quesenberry, Charles P., Jr.
    Engels, Eric A.
    Asgari, Maryam M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (05): : 350 - 360
  • [39] Cetuximab in non-melanoma skin cancer
    Wollina, Uwe
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (07) : 949 - 956
  • [40] Immunotherapy for Non-melanoma Skin Cancer
    Sophia Z. Shalhout
    Kevin S. Emerick
    Howard L. Kaufman
    David M. Miller
    Current Oncology Reports, 2021, 23